Analyst firms · Morgan Stanley · PAYX
Morgan Stanley PAYX price target and rating history
Paychex Inc. (PAYX) · Industrials
Morgan Stanley rates Paychex Inc. (PAYX) Equal-Weight with a $135 price target, as of its latest action on Dec 23, 2021. It has published 4 rating actions on PAYX since June 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a PAYX price target in the last 12 months, the median target is $120.
- Current rating
- Equal-Weight
- Price target
- $135
- Median target, all firms
- $120
- Actions on PAYX
- 4
Morgan Stanley price target on PAYX
Every Morgan Stanley rating on PAYX
- Dec 23, 2021
- Oct 4, 2021
- Oct 1, 2021
- Jun 28, 2021
How other firms rate PAYX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Neutral | $120 | Nov 19, 2026 |
| BMO Capital Markets | Market Perform | $113 | Sep 24, 2026 |
| Wolfe Research | Peer Perform | Sep 16, 2026 | |
| Stephens | Equal-Weight | $132 | Sep 4, 2026 |
| Citigroup | Buy | $140 | Jun 15, 2026 |
| Guggenheim | Neutral | Mar 19, 2026 | |
| Cantor Fitzgerald | Underweight | $98 | Jan 27, 2026 |
Questions about Morgan Stanley and PAYX
- What is Morgan Stanley's price target for PAYX?
- Morgan Stanley's latest stated price target for Paychex Inc. (PAYX) is $135, from its action on Dec 23, 2021.
- What is Morgan Stanley's rating on PAYX?
- Morgan Stanley rates PAYX Equal-Weight, a neutral rating, as of Dec 23, 2021.
- When did Morgan Stanley last change its view on PAYX?
- On Dec 23, 2021, Morgan Stanley raises its price target to $135 from $105, keeps Equal-Weight.
- How does Morgan Stanley's PAYX target compare with other analysts?
- Across 5 firms with a PAYX price target in the last 12 months, the median target is $120.
More PAYX rating histories
All Morgan Stanley ratingsPAYX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.